Business news from Ukraine

Business news from Ukraine

THE EMBASSY OF INDIA IN UKRAINE, IPMA AND PHARMEXCIL ORGANIZE BUSINESS SEMINAR, ACCREDITATION FOR MEDIA IS OBLIGATORY

The Embassy of India in Kyiv, in association with Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) and Indian Pharmaceuticals Manufacturers Association (IPMA), Ukraine is organizing the annual business seminar on pharmaceutical and herbal sectors “India- a Global Power in Pharmaceutical Sector: a Reliable Partner for Ukraine” on 30th November, 2018 in Kyiv to promote and display the potential of India in these sectors.
For more information, please send a request to the e-mail com.kyiv.india@gmail.com.
Accreditation for media representatives is obligatory under the following link: goo.gl/7cGuVS

, , , ,

BUSINESS DELEGATION OF PHARMEXCIL WILL VISIT UKRAINE IN LATE NOV

The business delegation of Pharmexcil, the Pharmaceuticals Export Promotion Council of India, will visit three importing countries, including Ukraine, Turkmenistan and the Russian Federation at the end of November. The Indian Pharmaceutical Manufacturer’s Association (IPMA) said the delegation of Pharmexcil will hold business meetings with the local pharmaceutical companies and regulatory agencies to stimulate Indian pharmaceutical exports.
In Kyiv, the delegation of Pharmexcil will meet with the representatives of the Ministry of Health and pharmaceutical companies.
According to Pharmexcil, the sales of Indian medicines in Ukraine in 2017-2018 increased by 14.4%, to $95.96 million. In the 2016-2017 fiscal year, India exported pharmaceutical products worth $83.91 million to Ukraine.
India as a manufacturer in Ukraine in 2017 ranked third in terms of pharmacy sales in packages after Ukraine and Germany, and in monetary terms (in the national currency) it ranked fourth after Ukraine, Germany, and the United Kingdom. Among the Indian pharmaceutical companies that are actively working in Ukraine, in particular, are Macleods Pharmaceutical, Dr Reddy’s, Euro Lifecare Ltd.

, , ,